Sample size in cluster-randomized trials with time to event as the primary endpoint

In cluster‐randomized trials, groups of individuals (clusters) are randomized to the treatments or interventions to be compared. In many of those trials, the primary objective is to compare the time for an event to occur between randomized groups, and the shared frailty model well fits clustered tim...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Statistics in medicine 2013-02, Vol.32 (5), p.739-751
Hauptverfasser: Jahn-Eimermacher, Antje, Ingel, Katharina, Schneider, Astrid
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 751
container_issue 5
container_start_page 739
container_title Statistics in medicine
container_volume 32
creator Jahn-Eimermacher, Antje
Ingel, Katharina
Schneider, Astrid
description In cluster‐randomized trials, groups of individuals (clusters) are randomized to the treatments or interventions to be compared. In many of those trials, the primary objective is to compare the time for an event to occur between randomized groups, and the shared frailty model well fits clustered time‐to‐event data. Members of the same cluster tend to be more similar than members of different clusters, causing correlations. As correlations affect the power of a trial to detect intervention effects, the clustered design has to be considered in planning the sample size. In this publication, we derive a sample size formula for clustered time‐to‐event data with constant marginal baseline hazards and correlation within clusters induced by a shared frailty term. The sample size formula is easy to apply and can be interpreted as an extension of the widely used Schoenfeld's formula, accounting for the clustered design of the trial. Simulations confirm the validity of the formula and its use also for non‐constant marginal baseline hazards. Findings are illustrated on a cluster‐randomized trial investigating methods of disseminating quality improvement to addiction treatment centers in the USA. Copyright © 2012 John Wiley & Sons, Ltd.
doi_str_mv 10.1002/sim.5548
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1285462901</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1285462901</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3878-8dca760cec26ce978b8a938d48167f74bc2038dce7c726af2846ec74b80a9c103</originalsourceid><addsrcrecordid>eNp1kFtLBCEYQCWK2i7QLwihl15mU2dGnceKLhvdt-hRXOdbsuayqdPt12c1FQQ9iR_Hg99BaJ2SISWEbXtbD_M8k3NoQEkhEsJyOY8GhAmRcEHzJbTs_T0hlOZMLKIlxiTPJRUDNB7relYB9vYNsG2wqTofwCVON2Vbx2GJg7O68vjZhjscbA04tBieoAlYexzuAM-crbV7xdCUs9Y2YRUtTOMLWOvPFXRzsH-9d5ScnB-O9nZOEpNKIRNZGi04MWAYN1AIOZG6SGWZScrFVGQTw0i8GhBGMK6nTGYcTJxLogtDSbqCtr68M9c-duCDqq03UFW6gbbzijKZZ5wVhEZ08w9633auib_7pJhIueS_QuNa7x1MVb-aokR9hFYxtPoIHdGNXthNaih_wO-yEUi-gGdbweu_IjUenfbCnrex_8sPr92D4iIVubo9O1RXxxe7_Do7UpfpO-tXldM</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1285273686</pqid></control><display><type>article</type><title>Sample size in cluster-randomized trials with time to event as the primary endpoint</title><source>MEDLINE</source><source>Access via Wiley Online Library</source><creator>Jahn-Eimermacher, Antje ; Ingel, Katharina ; Schneider, Astrid</creator><creatorcontrib>Jahn-Eimermacher, Antje ; Ingel, Katharina ; Schneider, Astrid</creatorcontrib><description>In cluster‐randomized trials, groups of individuals (clusters) are randomized to the treatments or interventions to be compared. In many of those trials, the primary objective is to compare the time for an event to occur between randomized groups, and the shared frailty model well fits clustered time‐to‐event data. Members of the same cluster tend to be more similar than members of different clusters, causing correlations. As correlations affect the power of a trial to detect intervention effects, the clustered design has to be considered in planning the sample size. In this publication, we derive a sample size formula for clustered time‐to‐event data with constant marginal baseline hazards and correlation within clusters induced by a shared frailty term. The sample size formula is easy to apply and can be interpreted as an extension of the widely used Schoenfeld's formula, accounting for the clustered design of the trial. Simulations confirm the validity of the formula and its use also for non‐constant marginal baseline hazards. Findings are illustrated on a cluster‐randomized trial investigating methods of disseminating quality improvement to addiction treatment centers in the USA. Copyright © 2012 John Wiley &amp; Sons, Ltd.</description><identifier>ISSN: 0277-6715</identifier><identifier>EISSN: 1097-0258</identifier><identifier>DOI: 10.1002/sim.5548</identifier><identifier>PMID: 22865817</identifier><identifier>CODEN: SMEDDA</identifier><language>eng</language><publisher>Chichester, UK: John Wiley &amp; Sons, Ltd</publisher><subject>Biostatistics - methods ; Clinical trials ; Cluster Analysis ; cluster randomized ; correlated ; Correlation analysis ; Endpoint Determination - statistics &amp; numerical data ; Frailty ; Humans ; Likelihood Functions ; Models, Statistical ; Poisson Distribution ; Random Allocation ; Randomized Controlled Trials as Topic - statistics &amp; numerical data ; Regression Analysis ; Sample Size ; Simulation ; Substance Abuse Treatment Centers - statistics &amp; numerical data ; Substance-Related Disorders - therapy ; survival ; Time Factors ; time to event ; Time-to-Treatment</subject><ispartof>Statistics in medicine, 2013-02, Vol.32 (5), p.739-751</ispartof><rights>Copyright © 2012 John Wiley &amp; Sons, Ltd.</rights><rights>Copyright John Wiley and Sons, Limited Feb 28, 2013</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3878-8dca760cec26ce978b8a938d48167f74bc2038dce7c726af2846ec74b80a9c103</citedby><cites>FETCH-LOGICAL-c3878-8dca760cec26ce978b8a938d48167f74bc2038dce7c726af2846ec74b80a9c103</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1002%2Fsim.5548$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1002%2Fsim.5548$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,780,784,1417,27924,27925,45574,45575</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/22865817$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Jahn-Eimermacher, Antje</creatorcontrib><creatorcontrib>Ingel, Katharina</creatorcontrib><creatorcontrib>Schneider, Astrid</creatorcontrib><title>Sample size in cluster-randomized trials with time to event as the primary endpoint</title><title>Statistics in medicine</title><addtitle>Statist. Med</addtitle><description>In cluster‐randomized trials, groups of individuals (clusters) are randomized to the treatments or interventions to be compared. In many of those trials, the primary objective is to compare the time for an event to occur between randomized groups, and the shared frailty model well fits clustered time‐to‐event data. Members of the same cluster tend to be more similar than members of different clusters, causing correlations. As correlations affect the power of a trial to detect intervention effects, the clustered design has to be considered in planning the sample size. In this publication, we derive a sample size formula for clustered time‐to‐event data with constant marginal baseline hazards and correlation within clusters induced by a shared frailty term. The sample size formula is easy to apply and can be interpreted as an extension of the widely used Schoenfeld's formula, accounting for the clustered design of the trial. Simulations confirm the validity of the formula and its use also for non‐constant marginal baseline hazards. Findings are illustrated on a cluster‐randomized trial investigating methods of disseminating quality improvement to addiction treatment centers in the USA. Copyright © 2012 John Wiley &amp; Sons, Ltd.</description><subject>Biostatistics - methods</subject><subject>Clinical trials</subject><subject>Cluster Analysis</subject><subject>cluster randomized</subject><subject>correlated</subject><subject>Correlation analysis</subject><subject>Endpoint Determination - statistics &amp; numerical data</subject><subject>Frailty</subject><subject>Humans</subject><subject>Likelihood Functions</subject><subject>Models, Statistical</subject><subject>Poisson Distribution</subject><subject>Random Allocation</subject><subject>Randomized Controlled Trials as Topic - statistics &amp; numerical data</subject><subject>Regression Analysis</subject><subject>Sample Size</subject><subject>Simulation</subject><subject>Substance Abuse Treatment Centers - statistics &amp; numerical data</subject><subject>Substance-Related Disorders - therapy</subject><subject>survival</subject><subject>Time Factors</subject><subject>time to event</subject><subject>Time-to-Treatment</subject><issn>0277-6715</issn><issn>1097-0258</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2013</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp1kFtLBCEYQCWK2i7QLwihl15mU2dGnceKLhvdt-hRXOdbsuayqdPt12c1FQQ9iR_Hg99BaJ2SISWEbXtbD_M8k3NoQEkhEsJyOY8GhAmRcEHzJbTs_T0hlOZMLKIlxiTPJRUDNB7relYB9vYNsG2wqTofwCVON2Vbx2GJg7O68vjZhjscbA04tBieoAlYexzuAM-crbV7xdCUs9Y2YRUtTOMLWOvPFXRzsH-9d5ScnB-O9nZOEpNKIRNZGi04MWAYN1AIOZG6SGWZScrFVGQTw0i8GhBGMK6nTGYcTJxLogtDSbqCtr68M9c-duCDqq03UFW6gbbzijKZZ5wVhEZ08w9633auib_7pJhIueS_QuNa7x1MVb-aokR9hFYxtPoIHdGNXthNaih_wO-yEUi-gGdbweu_IjUenfbCnrex_8sPr92D4iIVubo9O1RXxxe7_Do7UpfpO-tXldM</recordid><startdate>20130228</startdate><enddate>20130228</enddate><creator>Jahn-Eimermacher, Antje</creator><creator>Ingel, Katharina</creator><creator>Schneider, Astrid</creator><general>John Wiley &amp; Sons, Ltd</general><general>Wiley Subscription Services, Inc</general><scope>BSCLL</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>K9.</scope><scope>7X8</scope></search><sort><creationdate>20130228</creationdate><title>Sample size in cluster-randomized trials with time to event as the primary endpoint</title><author>Jahn-Eimermacher, Antje ; Ingel, Katharina ; Schneider, Astrid</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3878-8dca760cec26ce978b8a938d48167f74bc2038dce7c726af2846ec74b80a9c103</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2013</creationdate><topic>Biostatistics - methods</topic><topic>Clinical trials</topic><topic>Cluster Analysis</topic><topic>cluster randomized</topic><topic>correlated</topic><topic>Correlation analysis</topic><topic>Endpoint Determination - statistics &amp; numerical data</topic><topic>Frailty</topic><topic>Humans</topic><topic>Likelihood Functions</topic><topic>Models, Statistical</topic><topic>Poisson Distribution</topic><topic>Random Allocation</topic><topic>Randomized Controlled Trials as Topic - statistics &amp; numerical data</topic><topic>Regression Analysis</topic><topic>Sample Size</topic><topic>Simulation</topic><topic>Substance Abuse Treatment Centers - statistics &amp; numerical data</topic><topic>Substance-Related Disorders - therapy</topic><topic>survival</topic><topic>Time Factors</topic><topic>time to event</topic><topic>Time-to-Treatment</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Jahn-Eimermacher, Antje</creatorcontrib><creatorcontrib>Ingel, Katharina</creatorcontrib><creatorcontrib>Schneider, Astrid</creatorcontrib><collection>Istex</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>MEDLINE - Academic</collection><jtitle>Statistics in medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Jahn-Eimermacher, Antje</au><au>Ingel, Katharina</au><au>Schneider, Astrid</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Sample size in cluster-randomized trials with time to event as the primary endpoint</atitle><jtitle>Statistics in medicine</jtitle><addtitle>Statist. Med</addtitle><date>2013-02-28</date><risdate>2013</risdate><volume>32</volume><issue>5</issue><spage>739</spage><epage>751</epage><pages>739-751</pages><issn>0277-6715</issn><eissn>1097-0258</eissn><coden>SMEDDA</coden><abstract>In cluster‐randomized trials, groups of individuals (clusters) are randomized to the treatments or interventions to be compared. In many of those trials, the primary objective is to compare the time for an event to occur between randomized groups, and the shared frailty model well fits clustered time‐to‐event data. Members of the same cluster tend to be more similar than members of different clusters, causing correlations. As correlations affect the power of a trial to detect intervention effects, the clustered design has to be considered in planning the sample size. In this publication, we derive a sample size formula for clustered time‐to‐event data with constant marginal baseline hazards and correlation within clusters induced by a shared frailty term. The sample size formula is easy to apply and can be interpreted as an extension of the widely used Schoenfeld's formula, accounting for the clustered design of the trial. Simulations confirm the validity of the formula and its use also for non‐constant marginal baseline hazards. Findings are illustrated on a cluster‐randomized trial investigating methods of disseminating quality improvement to addiction treatment centers in the USA. Copyright © 2012 John Wiley &amp; Sons, Ltd.</abstract><cop>Chichester, UK</cop><pub>John Wiley &amp; Sons, Ltd</pub><pmid>22865817</pmid><doi>10.1002/sim.5548</doi><tpages>13</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0277-6715
ispartof Statistics in medicine, 2013-02, Vol.32 (5), p.739-751
issn 0277-6715
1097-0258
language eng
recordid cdi_proquest_miscellaneous_1285462901
source MEDLINE; Access via Wiley Online Library
subjects Biostatistics - methods
Clinical trials
Cluster Analysis
cluster randomized
correlated
Correlation analysis
Endpoint Determination - statistics & numerical data
Frailty
Humans
Likelihood Functions
Models, Statistical
Poisson Distribution
Random Allocation
Randomized Controlled Trials as Topic - statistics & numerical data
Regression Analysis
Sample Size
Simulation
Substance Abuse Treatment Centers - statistics & numerical data
Substance-Related Disorders - therapy
survival
Time Factors
time to event
Time-to-Treatment
title Sample size in cluster-randomized trials with time to event as the primary endpoint
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-19T14%3A05%3A20IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Sample%20size%20in%20cluster-randomized%20trials%20with%20time%20to%20event%20as%20the%20primary%20endpoint&rft.jtitle=Statistics%20in%20medicine&rft.au=Jahn-Eimermacher,%20Antje&rft.date=2013-02-28&rft.volume=32&rft.issue=5&rft.spage=739&rft.epage=751&rft.pages=739-751&rft.issn=0277-6715&rft.eissn=1097-0258&rft.coden=SMEDDA&rft_id=info:doi/10.1002/sim.5548&rft_dat=%3Cproquest_cross%3E1285462901%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1285273686&rft_id=info:pmid/22865817&rfr_iscdi=true